SALIVARY GLAND CANCER

This study is observing how well the drug T-DXd works for people with advanced HER2-positive cancers who have already tried other treatments and have no good options left. It will follow about 100 patients in real-world US clinics to see how their tumors respond and how long the …

This study is testing an experimental drug called zanidatamab for people with advanced cancers that have a specific genetic marker called HER2. The trial will enroll about 200 adults whose cancers have progressed after at least one prior treatment. Researchers want to see if the …

This study is testing whether adding the drug T-DM1 to standard radiation and chemotherapy after surgery can help prevent cancer from coming back in people with HER2-positive salivary gland cancer. The drug specifically targets cancer cells that have the HER2 protein. About 55 pa…

This study is building a large, long-term database of health information and biological samples from people with cancer, people at risk for cancer, and healthy volunteers. The goal is to collect this data to help researchers better understand what causes cancer and how to prevent…

This study is testing a tiny, needle-tip-sized device that can be implanted into a head or neck cancer tumor. The device releases tiny amounts of up to 20 different drugs into the tumor for a few days before it is removed during the patient's scheduled surgery. The goal is to saf…